Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changlei Bao

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Hypertension (Dallas, Tex. : 1979)|April 22, 2026
Upregulation of CXCL10/CXCR3 Axis Induced by Pulmonary Hemodynamic Stress Promotes Vascular Remodeling in Chronic Thromboembolic Pulmonary HypertensionJianmin Lu, Huizhao Liao, Zijie Huang, et al.
Frontiers in Cell and Developmental Biology|August 23, 2021
Hypoxia-Inducible Factor 2-Alpha Mediated Gene Sets Differentiate Pulmonary Arterial HypertensionJinsheng Zhu, Li Zhao, Yadan Hu, et al.
Frontiers in Pharmacology|December 3, 2021
Combination Therapy With Rapamycin and Low Dose Imatinib in Pulmonary HypertensionYinan Shi, Chenxin Gu, Tongtong Zhao, et al.
American Journal of Respiratory Cell and Molecular Biology|January 31, 2022
Gut Microbial Metabolite Trimethylamine <i>N</i>-Oxide Aggravates Pulmonary HypertensionYuhang Huang, Fanjie Lin, Ruidi Tang, et al.
Oxidative Medicine and Cellular Longevity|June 27, 2022
Artemisinin and Its Derivate Alleviate Pulmonary Hypertension and Vasoconstriction in Rodent ModelsChanglei Bao, Qian He, Hui Wang, et al.
Microbiological Research|October 6, 2022
Microbiome and metabolome dysbiosis of the gut-lung axis in pulmonary hypertensionJiyuan Chen, Dansha Zhou, Jinrui Miao, et al.
Signal Transduction and Targeted Therapy|July 14, 2023
SARS-CoV-2 spike protein receptor-binding domain perturbates intracellular calcium homeostasis and impairs pulmonary vascular endothelial cellsKai Yang, Shiyun Liu, Han Yan, et al.
Hypertension (Dallas, Tex. : 1979)|November 8, 2022
The Novel Lysosomal Autophagy Inhibitor (ROC-325) Ameliorates Experimental Pulmonary HypertensionChanglei Bao, Shuxin Liang, Ying Han, et al.
Signal Transduction and Targeted Therapy|March 9, 2023
SARS-CoV-2 spike protein induces IL-18-mediated cardiopulmonary inflammation via reduced mitophagyShuxin Liang, Changlei Bao, Zi Yang, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2025
Deficient FANCL Predisposes to Endothelial Damage: A New Therapeutic Target for Pulmonary HypertensionShiyun Liu, Xiaoqian Shan, Yufei Sun, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Hypertension (Dallas, Tex. : 1979)|April 22, 2026
Upregulation of CXCL10/CXCR3 Axis Induced by Pulmonary Hemodynamic Stress Promotes Vascular Remodeling in Chronic Thromboembolic Pulmonary HypertensionJianmin Lu, Huizhao Liao, Zijie Huang, et al.
Frontiers in Cell and Developmental Biology|August 23, 2021
Hypoxia-Inducible Factor 2-Alpha Mediated Gene Sets Differentiate Pulmonary Arterial HypertensionJinsheng Zhu, Li Zhao, Yadan Hu, et al.
Frontiers in Pharmacology|December 3, 2021
Combination Therapy With Rapamycin and Low Dose Imatinib in Pulmonary HypertensionYinan Shi, Chenxin Gu, Tongtong Zhao, et al.
American Journal of Respiratory Cell and Molecular Biology|January 31, 2022
Gut Microbial Metabolite Trimethylamine <i>N</i>-Oxide Aggravates Pulmonary HypertensionYuhang Huang, Fanjie Lin, Ruidi Tang, et al.
Oxidative Medicine and Cellular Longevity|June 27, 2022
Artemisinin and Its Derivate Alleviate Pulmonary Hypertension and Vasoconstriction in Rodent ModelsChanglei Bao, Qian He, Hui Wang, et al.
Microbiological Research|October 6, 2022
Microbiome and metabolome dysbiosis of the gut-lung axis in pulmonary hypertensionJiyuan Chen, Dansha Zhou, Jinrui Miao, et al.
Signal Transduction and Targeted Therapy|July 14, 2023
SARS-CoV-2 spike protein receptor-binding domain perturbates intracellular calcium homeostasis and impairs pulmonary vascular endothelial cellsKai Yang, Shiyun Liu, Han Yan, et al.
Hypertension (Dallas, Tex. : 1979)|November 8, 2022
The Novel Lysosomal Autophagy Inhibitor (ROC-325) Ameliorates Experimental Pulmonary HypertensionChanglei Bao, Shuxin Liang, Ying Han, et al.
Signal Transduction and Targeted Therapy|March 9, 2023
SARS-CoV-2 spike protein induces IL-18-mediated cardiopulmonary inflammation via reduced mitophagyShuxin Liang, Changlei Bao, Zi Yang, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2025
Deficient FANCL Predisposes to Endothelial Damage: A New Therapeutic Target for Pulmonary HypertensionShiyun Liu, Xiaoqian Shan, Yufei Sun, et al.
Pageof 3